The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

被引：0
|
作者：
Chiao-En Wu
Chan-Keng Yang
Meng-Ting Peng
Pei-Wei Huang
Ching-Fu Chang
Kun-Yun Yeh
Chun-Bing Chen
Chih-Liang Wang
Chao-Wei Hsu
I-Wen Chen
Cheng-Tao Lin
Shir-Hwa Ueng
Gigin Lin
Yu-Fen Lin
Chi-Yuan Cheng
John Wen-Cheng Chang
机构：
[1] Chang Gung Memorial Hospital,Division of Haematology
[2] Chang Gung University College of Medicine,Oncology, Department of Internal Medicine
[3] Chang Gung Memorial Hospital at Linkou,Immuno
[4] Chang Gung Memorial Hospital,Oncology Center of Excellence
[5] Chang Gung University College of Medicine,Division of Hemato
[6] Chang Gung Memorial Hospital at Linkou,Oncology, Department of Internal Medicine
[7] Chang Gung Memorial Hospital,Department of Dermatology
[8] Chang Gung Memorial Hospital,Department of Thoracic Medicine
[9] Chang Gung Memorial Hospital,Department of Gastroenterology and Hepatology
[10] ,Division of Endocrinology and Metabolism, Department of Internal Medicine
[11] Chang Gung Memorial Hospital,Department of Obstetrics and Gynecology
[12] Chang Gung Memorial Hospital,Department of Pathology
[13] Chang Gung Memorial Hospital,Department of Medical Imaging & Intervention
[14] Chang Gung Memorial Hospital,Department of Nursing
[15] ,Department of Pharmacy
[16] Chang Gung Memorial Hospital,undefined
来源：
BMC Cancer | / 20卷
关键词：
Immune checkpoint inhibitors; irAE; Skin toxicity; Vitiligo; Endocrine; Melanoma; PD-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
    Wu, Chiao-En
    Yang, Chan-Keng
    Peng, Meng-Ting
    Huang, Pei-Wei
    Chang, Ching-Fu
    Yeh, Kun-Yun
    Chen, Chun-Bing
    Wang, Chih-Liang
    Hsu, Chao-Wei
    Chen, I-Wen
    Lin, Cheng-Tao
    Ueng, Shir-Hwa
    Lin, Gigin
    Lin, Yu-Fen
    Cheng, Chi-Yuan
    Chang, John Wen-Cheng
    [J]. BMC CANCER, 2020, 20 (01)
  • [2] Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
    Suo, Aleksi
    Chan, Yin
    Beaulieu, Carissa
    Kong, Shiying
    Cheung, Winson Y.
    Monzon, Jose G.
    Smylie, Michael
    Walker, John
    Morris, Don
    Cheng, Tina
    [J]. ONCOLOGIST, 2020, 25 (05): : 438 - 446
  • [3] Anti-PD-1 antibodies: immune-related adverse events and efficacy
    [J]. Reactions Weekly, 2019, 1739 (1) : 6 - 6
  • [4] Prognostic significance of immune-related adverse events and immunosuppression in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Karapetyan, Lilit
    Bruno, Sabrina
    Abushukair, Hassan Mohammed
    Bo, Na
    Wang, Hong
    Sander, Cindy
    Kirkwood, John M. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
    Rogado Revuelta, Jacobo
    Romero-Laorden, Nuria
    Sanchez Torres, Jose Miguel
    Pacheco-Barcia, Vilma
    Ballesteros, Anabel
    Maria Ramos-Levi, Ana
    Arranz, Reyes
    Lorenzo, Alicia
    Gullon, Pedro
    Garrido Garcia, Ana
    Maria Serra, Jose
    Donnay, Olga
    Adrados, Magdalena
    Costas, Pablo
    Aspa, Javier
    Alfranca, Arantza
    Fenor De la Maza, Maria Dolores
    Mondejar, Rebeca
    Colomer, Ramon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies
    Oya, Kazumasa
    Nakamura, Yoshiyuki
    Shen, Larina Tzu-Wei
    Ishizuki, Shoichiro
    Matsusaka, Satoshi
    Fujisawa, Yasuhiro
    [J]. JOURNAL OF DERMATOLOGY, 2024, 51 (06): : 807 - 815
  • [7] Serum multiplex analysis of checkpoint proteins in association with immune-related adverse events in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Bruno, Sabrina
    Layding, Caroline Jane
    Wang, Hong
    Sander, Cindy
    Storkus, Walter J.
    Karapetyan, Lilit
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients
    Rogado, J.
    Sanchez-Torres, J. M.
    Romero-Laorden, N.
    Ballesteros, A., I
    Pacheco-Barcia, V
    Ramos-Levi, A.
    Arranz, R.
    Lorenzo, A.
    Gullon, P.
    Donnay, O.
    Adrados, M.
    Costas, P.
    Aspa, J.
    Alfranca, A.
    Mondejar, R.
    Colomer, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 109 : 21 - 27
  • [9] Immune-related adverse events with resumed anti-PD-1 therapy
    [J]. Reactions Weekly, 2017, 1676 (1) : 4 - 4
  • [10] Association between immune-related adverse events and efficacy of PD-1 inhibitors in Chinese patients with advanced melanoma
    Zhao, Jing-Jing
    Wen, Xi-Zhi
    Ding, Ya
    Li, Dan-Dan
    Zhu, Bao-Yan
    Li, Jing-Jing
    Weng, De-Sheng
    Zhang, Xing
    Zhang, Xiao-Shi
    [J]. AGING-US, 2020, 12 (11): : 10663 - 10675
12345